98%
921
2 minutes
20
ObjectivesThe aim of this study was to compare the clinicopathological characteristics and outcomes of lupus nephritis (LN) between late-onset and early-onset systemic lupus erythematosus (SLE) patients.MethodsWe reviewed the clinical, serological and histological characteristics of all patients with LN admitted to our nephrology unit between 2007 and 2024. Our patients were divided into two groups according to their age at diagnosis: Early-onset SLE (younger than 50 years) and late-onset SLE (50 years or older).ResultsA total of 231 patients were recruited, of whom 43 had late-onset SLE and 188 had early-onset SLE. The mean age at diagnosis of SLE was 58.36 ± 7.61 years in the late-onset SLE group and 29.23 ± 9.03 years in the early-onset SLE group. There was no difference in the time from SLE diagnosis to LN. Compared with early-onset group, late-onset group had a higher prevalence of discoid rash but a lower frequency of leukopenia. Late-onset patients had higher serum creatinine levels and lower prevalence of anti-SSA and anti-RNP antibodies. The frequency of class VI LN was statistically significantly higher in the late-onset group. The use of oral corticosteroids, hydroxychloroquine and immunosuppressive drugs was significantly lower in late-onset SLE patients than in early-onset SLE patients. The latter were significantly less likely to progress to chronic kidney disease.ConclusionOur results indicate that SLE patients have different clinical, serological and histological manifestations depending on the age at onset of the disease. Late-onset SLE patients are more likely to have rheumatoid arthritis at onset. They have more severe chronic renal lesions and a worse renal outcome.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/09612033251374770 | DOI Listing |
Lupus
August 2025
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.
ObjectivesThe aim of this study was to compare the clinicopathological characteristics and outcomes of lupus nephritis (LN) between late-onset and early-onset systemic lupus erythematosus (SLE) patients.MethodsWe reviewed the clinical, serological and histological characteristics of all patients with LN admitted to our nephrology unit between 2007 and 2024. Our patients were divided into two groups according to their age at diagnosis: Early-onset SLE (younger than 50 years) and late-onset SLE (50 years or older).
View Article and Find Full Text PDFLupus
August 2025
Department of Internal Medicine, Rheumatology Unit - Clinics Hospital of Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil.
BackgroundSystemic Lupus Erythematosus (SLE) is a heterogeneous multisystem autoimmune disease, with variable severity, autoantibody profile, response to treatment, relapsing course and damage accrual. The age at disease onset may influence disease trajectory and prognosis, with remarkable differences of major organ involvement, disease activity, and prognosis. SLE clinical profile, activity indices, remission, and damage comparison were carried out in childhood-onset (cSLE), adult-onset (aSLE) and late-onset (lSLE) patients from a single-centre series.
View Article and Find Full Text PDFRheumatology (Oxford)
July 2025
Rheumatology Unit, Hospital General de México Dr Eduardo Liceaga, Mexico City, Mexico.
Objectives: To develop a systematic review of quantitative studies focused on identifying factors associated with delay in diagnosing and treating adult patients with systemic lupus erythematosus (SLE).
Methods: Electronic searches were conducted in Scopus, PubMed, and Web of Science for studies published up to July 15, 2024. Inclusion criteria were studies in adult patients that estimated delay in diagnosis and/or treatment, and associated barriers and facilitators.
J Rheumatol
August 2025
L.P. Whittall Garcia, MD, MSc, University of Toronto Lupus Clinic, Division of Rheumatology, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
Objective: Renal involvement in systemic lupus erythematosus (SLE) most commonly occurs in women in the reproductive age group; however, it may theoretically start at any age. In this study, we aimed to explore the effect of lupus nephritis (LN) stratified by age of onset, with a cutoff at 50 years, on clinical presentation and disease outcomes.
Methods: We included 246 inception cohort patients who developed LN during follow-up.
Cureus
May 2025
Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, JPN.
Systemic lupus erythematosus (SLE) may be exacerbated at any stage of pregnancy, complicating maternal and fetal outcomes. Additionally, pregnancies with SLE have a higher risk of preeclampsia (PE), requiring careful differentiation between SLE flare and PE when symptoms such as proteinuria emerge. We herein describe a 36-year-old pregnant woman with SLE who developed severe proteinuria (13 g/day) at 30 weeks of gestation without hypertension or thrombocytopenia.
View Article and Find Full Text PDF